The Phytochemical Micheliolide from the Champa Plant (Michelia Champaca) Supercharges Radiation Against Breast Cancer
Nikhil Prasad Fact checked by:Thailand Medical News Team May 26, 2026 49 minutes ago
Medical News: Scientists from Anhui University of Chinese Medicine, Anhui Medical University, the Hefei Institutes of Physical Sciences under the Chinese Academy of Sciences, and the Anhui Academy of Chinese Medicine in China have discovered that a natural plant compound called micheliolide, extracted from the Champa plant (Michelia champaca), could dramatically improve the effectiveness of radiation therapy against breast cancer.
Natural phytochemical micheliolide from the Champa plant helps radiation therapy destroy breast cancer while
boosting anti-tumor immune defenses
The findings are attracting attention because they suggest that this phytochemical not only helps radiation kill cancer cells more effectively, but also boosts the body’s own immune defenses against tumors.
What Is Micheliolide?
Micheliolide, often shortened to MCL, is a naturally occurring plant compound belonging to a group of chemicals known as sesquiterpene lactones. It was first isolated from plants belonging to the Magnolia family, including the fragrant Champa plant (Michelia champaca), which has long been used in traditional herbal medicine across Asia.
Previous studies have shown that micheliolide possesses anti-inflammatory, antibacterial, anti-fibrotic, and anti-cancer properties. Scientists have also been interested in the compound because it can cross the blood-brain barrier, making it potentially useful for difficult-to-treat cancers.
Researchers found that MCL can interfere with several cancer survival pathways, suppress harmful inflammation, and restore immune activity that tumors often shut down. These unique characteristics made scientists suspect that it could work as a powerful partner for radiation therapy.
Radiation Therapy Has a Hidden Problem
Radiation therapy remains one of the most widely used treatments for breast cancer. It damages cancer cell DNA and helps shrink tumors. However, scientists have discovered that radiation can also unintentionally activate defense systems inside tumors.
One of the most important defense molecules is PD-L1, a protein that acts like a protective cloak for cancer cells. PD-L1 disables immune cells called T cells that would normally attack tumors.
The new study showed that after radiation exposure, breast cancer cells steadily increased production of PD-L1 over time. In some breast cancer cell lines, PD-L1 levels became dramatically elevated within 72 hours after radiation treatment.
This means that while radiation kills many cancer cells, surviving tumor cells may become better at hiding from the immune system.
Micheliolide Blocks the Tumor Shield
The researchers then tested whether MCL could stop this dangerous rise in PD-L1.
The results were striking. Breast cancer cells treated with micheliolide before radiation showed much lower PD-L1 levels compared to cells exposed to radiation alone. In some experiments, PD-L1 levels almost returned to normal baseline levels.
Further investigation revealed that r
adiation activates a chain of signaling proteins known as IRF1 and STAT1. These proteins switch on PD-L1 production inside tumor cells. Micheliolide was able to suppress this signaling pathway, effectively preventing tumors from building their immune shield.
Researchers also discovered another surprising effect. MCL accelerated the destruction of existing PD-L1 proteins through the cell’s proteasome system, which acts like a cellular waste disposal mechanism.
This meant that micheliolide attacked PD-L1 in two ways at once: it reduced new PD-L1 production while also helping eliminate PD-L1 already present in cancer cells.
This
Medical News report highlights how this dual-action mechanism could become highly valuable in future cancer treatment strategies.
Strong Anti-Tumor Effects Seen in Animals
To determine whether the findings could work in living organisms, researchers tested the treatment in mice implanted with breast tumors.
Mice receiving both radiation and micheliolide showed the greatest tumor shrinkage compared to animals receiving either treatment alone. Tumors in the combined-treatment group became dramatically smaller and lighter.
Importantly, the tumors also showed far greater infiltration of CD8-positive T cells, which are the immune system’s specialized cancer-killing cells. Levels of granzyme B, a molecule used by immune cells to destroy cancer cells, were also significantly increased.
These findings suggest that MCL not only improves radiation effectiveness directly but also helps awaken anti-tumor immunity.
Conclusion
The study provides compelling new evidence that micheliolide from the Champa plant may become an important future tool for improving breast cancer radiotherapy. By blocking PD-L1 and restoring immune system activity, the compound appears capable of helping radiation therapy overcome one of cancer’s major survival strategies. The research also suggests that natural plant-derived compounds could play a growing role in modern oncology by enhancing conventional cancer treatments while potentially reducing resistance. Although human trials are still needed, the findings offer exciting hope that combining radiation therapy with immune-boosting phytochemicals like micheliolide may eventually improve survival outcomes for many breast cancer patients.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/11/4744
For the latest on breast cancer, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
Share
Tweet
Share
